OTC “Convenience-Size” Two-Dose Rule Should Allow For Exemptions – CHPA
This article was originally published in The Tan Sheet
Executive Summary
FDA should extend its classification of "convenience-size" OTCs beyond the two-dose limit outlined in a recent rule partially delaying "Drug Facts" labeling compliance for such products, the Consumer Healthcare Products Association says
You may also be interested in...
“Grandfathered” Category Of “Convenience-Size” OTCs Sought By GSK
FDA's rule partially delaying implementation of OTC labeling requirements for certain "convenience-size" drugs should be amended to include a category of "grandfathered" products, GlaxoSmithKline says in an Oct. 25 citizen petition
“Grandfathered” Category Of “Convenience-Size” OTCs Sought By GSK
FDA's rule partially delaying implementation of OTC labeling requirements for certain "convenience-size" drugs should be amended to include a category of "grandfathered" products, GlaxoSmithKline says in an Oct. 25 citizen petition
“Convenience-Size” OTCs Inner Package Labeling Limits Supported
FDA limits on the information that must appear on the inner package of one- and two-dose size OTC drugs are supported by drug relabeler Mechanical Servants in May 13 comments to the agency